CAMP4 Therapeutics competitorsClear all

Oxford BioTherapeutics's top competitors include MicrofluidX, Affinia Therapeutics and Nouscom.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
MicrofluidX
MicrofluidX
MicrofluidX is a company that develops cell bioprocessing technology.
Affinia Therapeutics
Affinia Therapeutics
Affinia Therapeutics is a biotech company.
Nouscom
Nouscom
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Founding Date
Founding Date
2004
Founding Date
2018
Founding Date
2019
Founding Date
2015
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Milton, GB HQ
San Jose, US
Locations
HQ
Locations
HQ
Locations
Basel, CH HQ
Roma, IT
Employees
Employees
28
Employees
5
Employees
623% increase
Employees
33

Funding

Latest funding round
Latest funding round
$ 10m (about 6 years ago)
Latest funding round
$ 1.7m (over 1 year ago)
Latest funding round
$ 60m (over 1 year ago)
Latest funding round
$ 49m (almost 4 years ago)
Total funding raised
Total funding raised
$ 21.6m
Total funding raised
$ 1.7m
Total funding raised
$ 60m
Total funding raised
$ 62.6m
For sources of this data, please see the company profile

View company profiles

MicrofluidX
HQ
Employees
5

MicrofluidX is a company that develops cell bioprocessing technology.

View company
Affinia Therapeutics
HQ
Employees
62↑ 3% increase

Affinia Therapeutics is a biotech company.

View company
Nouscom
HQ
Basel, CH
Employees
33

Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

View company